Thus, our results indicate that CXCL13 can induce sICAM‐1, and sICAM‐1 enhances T cells' proliferation and their effector function and reduces tumor mass, suggesting the potential of sICAM‐1 as a new anti‐tumor therapy. The gene discussed is CXCL13; the disease is neoplasm.